Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportEducational Exhibits - Oncology

NETs (Neuroendocrine tumours) – A pictorial review

Shubha G Ravindra, Sumit Garg, Aditi Khurana, Rakesh Kumar and Chandrasekhar Bal
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 241534;
Shubha G Ravindra
1All India Institute of Medical Sciences, New Delhi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sumit Garg
1All India Institute of Medical Sciences, New Delhi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aditi Khurana
2All India Institute of Medical Sciences, New Delhi , India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rakesh Kumar
3All India Institute of Medical Sciences, New Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chandrasekhar Bal
4All India Institute of Medical Sciences
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

241534

Introduction: Some of the commonly encountered NETs include – GEP NETs, bronchial NETs, neuroblastoma, pheochromocytoma, paraganglioma and medullary carcinoma thyroid. The radiotracers, characteristic locations of occurrence, imaging features and role of nuclear medicine imaging in these tumours will be described in this exhibit.

Methods: Some of the radiotracers discussed will include MIBG, SSTR agonists and DOPA with their relative advantages and disadvantages. A pictorial review of cases of NET – medullary carcinoma thyroid, bronchial carcinoid, GEP NET(WHO classification and grading; non-functional and functional – insulinoma, gastrinoma), neuroblastoma(various locations), pheochromocytoma, paraganglioma (various locations – head and neck (glomus tympanicum, glomus jugulare, glomus vagale, carotid body tumour; chest; abdominal) highlighting of role of nuclear imaging in various clinical scenarios will be provided including diagnosis, staging, response assessment, recurrence and therapy planning (assessment of tumour grade) including diagnostic pearls and pitfalls.

Results: The exhibit will be described under following headings – Radiotracers and their physiologic distribution; Case Scenarios using these radiotracers highlighting location, imaging features and specific role and Pearls and pitfalls.

Conclusions: In this exhibit, we present cases that highlight the role of nuclear imaging in various NETs.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
NETs (Neuroendocrine tumours) – A pictorial review
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
NETs (Neuroendocrine tumours) – A pictorial review
Shubha G Ravindra, Sumit Garg, Aditi Khurana, Rakesh Kumar, Chandrasekhar Bal
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241534;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
NETs (Neuroendocrine tumours) – A pictorial review
Shubha G Ravindra, Sumit Garg, Aditi Khurana, Rakesh Kumar, Chandrasekhar Bal
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241534;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors: Review of Treatment Workflow and Challenging Clinical Scenarios
  • Advances in Therapeutic Managements in Lymphoma and the Role of FDG-PET/CT in Therapeutic Decision-Making
  • Imaging biomarkers for response assessment in Neuroendocrine tumors and role of dual tracer imaging
Show more Educational Exhibits - Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire